Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Sponsors
/ Joint Stock Company "Farmak"
Joint Stock Company "Farmak"
Industry · 12 registered clinical trials.
Status
Trial
Phase
Started
Completed
Fasting Bioequivalence Study of 2 Metformin 500 mg Prolonged Release Tablets in 44 Healthy Male and Female Vol
Pharmacokinetics
Phase 1
2021-05-21
Completed
Fasted Bioequivalence Study of 2 Olanzapine Film-coated Tablets, 5 mg, in Healthy, Adult Male and Female Subje
Pharmacokinetics
Phase 1
2020-10-21
Completed
A Clinical Study to Assess the Efficacy and Safety of Amizon® Max in the Treatment of Moderate Covid-19, Cause
Covid-19 Disease
Phase 3
2020-05-15
Completed
Fasting Bioequivalence Study of 2 Oral Progesterone Soft Capsules 200 mg in 48 Healthy Female Subjects
Pharmacokinetics
Phase 1
2019-12-13
Completed
Fasting Bioequivalence Study of 2 Progesterone Soft Capsules 200 mg in 66 Healthy Female Subjects Under Vagina
Pharmacokinetics
Phase 1
2019-08-28
Completed
Fed Bioequivalence Study of 2 Metformin 500 mg Prolongued Release Tablets in 28 Healthy Male and Female Volunt
Pharmacokinetics
Phase 1
2019-06-25
Completed
Fasting Bioequivalence Study of 2 Metformin 1000 mg Prolonged Release Tablets in 28 Healthy Male and Female Vo
Pharmacokinetics
Phase 1
2019-04-03
Completed
Fed Bioequivalence Study of 2 Metformin 1000 mg Prolonged Release Tablets in 28 Healthy Male and Female Volunt
Pharmacokinetics
Phase 1
2019-01-11
Unknown
Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel
Rheumatoid Arthritis
Phase 3
2018-09-03
Completed
Fasted Bioequivalence Study of Clopidogrel Film-coated Tablets, 75 mg in 48 Healthy, Adult Male and Female Sub
Pharmacokinetics
Phase 1
2018-07-12
Completed
Fasting Comparative Bioavailability Study of 2 Meloxicam 15 mg Tablets in Healthy Volunteers Under Fasting Con
Pharmacokinetics
Phase 1
2014-01-29
Completed
Efficacy and Safety of Enisamium Iodide for the Treatment of Acute Respiratory Viral Infections, Including Inf
Acute Respiratory Viral Infections, Human Influenza
Phase 2 / Phase 3
2009-04-13